Clin2
NCT06395428Possibly a fitRecruiting

Haloperidol for severe back pain in the ER

Back PainChronic Pain

Treatments studied

Part of Pain clinical trials.

This study tests whether the medication haloperidol, given in the emergency room, can help relieve severe back pain that started on its own (not from an injury). It compares haloperidol to a common pain reliever called ketorolac.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
75 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have back pain that is not caused by an injury or accident.
  • Your back pain is severe (at least 7 out of 10 on a pain scale).
  • You do not have numbness in your groin area or trouble with bladder or bowel control.
  • You are not allergic to haloperidol or ketorolac.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07726069Not yet recruiting· Early Phase 1
Haloperidol for nausea caused by cannabis use in the ER

This study is testing whether a medicine called haloperidol can help manage symptoms of a condition linked to heavy cannabis use, called cannabinoid hyperemesis syndrome (which causes severe nausea and vomiting). If you often use cannabis and have these symptoms, this treatment might help you feel better while you are in the emergency room.

Chicago, Illinois
NCT06419439Recruiting· Phase 2
Ketamine for Veterans with Chronic Back Pain and Depression

This study tests whether ketamine, combined with talk therapy, can help veterans with both chronic low back pain and depression. The goal is to reduce pain and improve mood.

Ann Arbor, Michigan
NCT06364540Recruiting· Phase 4
Ketamine vs fentanyl for severe pain in the ER

This trial compares two inhaled pain relievers, ketamine and fentanyl, to see which works better for sudden, severe pain in the emergency room. You would receive one of these medicines through a breathing mask to help your pain quickly.

Brooklyn, New York
NCT07670507Not yet recruiting· Phase 2/Phase 3
Comparing oral ketamine and oral oxycodone for emergency pain

This study tests two pain medicines given by mouth in the emergency department—ketamine and oxycodone—to see which works better for acute pain. If you're in moderate to severe pain and the first painkiller didn't help, this trial may help you manage pain while advancing care.

Albany, New York
NCT06819956Recruiting· Phase 3
Lower-dose ketorolac for pain in the ICU

This trial tests whether a lower dose of the pain medicine ketorolac can safely control pain for people in the intensive care unit (ICU). If you are in the ICU and have pain, this study might help find a better way to treat it.

Edmonton, Alberta
NCT07816302Not yet recruiting· Phase 3
Nasal ketorolac for emergency pain relief

This study tests two strengths of a pain-relief nasal spray (ketorolac) to see which works better and is safe for adults with recent acute pain. It may offer a needle-free option for managing pain in the emergency department.

Hear when a new Back Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.